Peer-reviewed Article Reveals a New Spinal Surgery Technique

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

A new article that has just been published at the International Journal of Spine Surgery, discussing a Modified Transforaminal Thoracic Interbody Fusion Approach. The news was announced today by Carevature Medical.

The authors present a new technique for posterior unilateral thoracic discectomy, facilitated by the Dreal®, “a novel, curved, shielded, high-speed device”; Introducing the Dreal® ventrally to the dural sac allows removal of calcified and soft disc fragments without relying on forceful manual maneuvers and avoiding manipulation of the spinal cord, resulting in a “safer treatment for thoracic disc herniations, reducing complication rates and improving patient outcome.”

The technique was developed by neurosurgeon Ely Ashkenazi, MD, at the Assuta Medical Center (Tel Aviv, Israel) in the past 5 years and has become a standard for treating such pathologies in transforaminal thoracic interbody fusion procedures (TTIF) as described in the article, as well as in more common transforaminal lumbar interbody fusion procedures (TLIF).

Says orthopedic spine surgeon and lead author Michael Millgram, MD: “The Dreal® curved high-speed drill has proved a valuable addition to my clinical practice. It allows quick and thorough evacuation of disc material in TLIF procedures providing a large clean bony surface for fusion while reducing operating time. My impression is that TLIF procedures performed with the Dreal® exhibit a considerably more robust anterior fusion than those procedures where disc space preparation was performed in the standard manual manner.”

Dennis Farrell, President for Carevature Medical, Inc. comments: “This article presents one example of how Carevature technology has the potential to reduce the morbidity associated with spinal procedures. Our company is laser-focused on improving outcomes through novel technology which is designed to safely, efficiently, and effectively remove pathology while retaining structural anatomy and minimizing the collateral damage often associated with spine surgery. We are committed to modernizing the tools that are available for decompression, many of which have not changed in decades. Carevature continues to research, develop, and launch solutions that advance the art of the decompression through our family of sterile packed, single-use, curved at the tip, shielded, and high speed bone cutting technology, and are looking forward to additional publications that share the benefits of our growing experience in cervical (ACDF, ACCF, and foraminotomy) and lumbar (foraminotomy, osteophyte removal) procedures.”

To date, Carevature Medical’s Dreal® technology has assisted surgeons in over 1,500 cases, both non-fusion and fusion. The company’s highly targeted approach has it working with medical systems and surgeons located across the US, in Chicago, Boston, Dallas, Southern California, Michigan, North Carolina, and Florida, with plans to expand throughout 2020.



Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles